标题
Why hasn’t there been more progress in new Chagas disease drug discovery?
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume -, Issue -, Pages 1-14
出版商
Informa UK Limited
发表日期
2019-11-01
DOI
10.1080/17460441.2020.1681394
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chagas Cardiomyopathy in Latin America Review
- (2019) Jefferson Luis Vieira et al. Current Cardiology Reports
- Correction: Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis
- (2019) María A. Natale et al. PLoS Neglected Tropical Diseases
- Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity
- (2018) Bianca Zingales ACTA TROPICA
- From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases
- (2018) LEONARDO G. FERREIRA et al. ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
- Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice
- (2018) Lívia de Figueiredo Diniz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Current advances in drug discovery for Chagas disease
- (2018) Cauê Benito Scarim et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
- (2018) Faustino Torrico et al. LANCET INFECTIOUS DISEASES
- A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging
- (2018) Erica Silberstein et al. PLoS One
- Response to different benznidazole doses in animal models of chronic phase Chagas disease: a critical review
- (2018) Cauê Benito Scarim et al. Revista da Sociedade Brasileira de Medicina Tropical
- A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients
- (2018) Maan Zrein et al. PLoS Neglected Tropical Diseases
- The rise of neglected tropical diseases in the "new Texas"
- (2018) Peter J. Hotez PLoS Neglected Tropical Diseases
- Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis
- (2018) Lyda Z. Rojas et al. PLoS Neglected Tropical Diseases
- Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery
- (2018) Lorna M. MacLean et al. PLoS Neglected Tropical Diseases
- Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure
- (2018) Fernando J Sánchez-Valdéz et al. eLife
- Innovation in neglected tropical disease drug discovery and development
- (2018) Hong-Bo Weng et al. Infectious Diseases of Poverty
- In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
- (2018) Raimunda S. S. Azevedo et al. Scientific Reports
- Is the priority review voucher program stimulating new drug development for tropical diseases?
- (2018) Kirk W. Kerr et al. PLoS Neglected Tropical Diseases
- Update on drug development targeting parasite cysteine proteases
- (2018) James H. McKerrow PLoS Neglected Tropical Diseases
- Alleviating the Neglected Tropical Diseases: Recent Developments in Diagnostics and Detection
- (2018) Satakshi Hazra et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- N-Nitrosulfonamides as Carbonic Anhydrase Inhibitors: A Promising Chemotype for Targeting Chagas Disease and Leishmaniasis
- (2018) Alessandro Bonardi et al. ACS Medicinal Chemistry Letters
- Advances on Aptamers against Protozoan Parasites
- (2018) Juan Ospina-Villa et al. Genes
- Drug Discovery for Kinetoplastid Diseases: Future Directions
- (2018) Srinivasa P. S. Rao et al. ACS Infectious Diseases
- Chagas disease
- (2018) Dan M. Tzizik et al. JAAPA-Journal of the American Academy of Physician Assistants
- Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening
- (2018) Cleber C. Melo-Filho et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phenotypic screening approaches for Chagas disease drug discovery
- (2017) Eric Chatelain et al. Expert Opinion on Drug Discovery
- Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosoma cruzi
- (2017) Alane Beatriz Vermelho et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers
- (2017) Carlos A. Morillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recently differentiated epimastigotes from Trypanosoma cruzi are infective to the mammalian host
- (2017) Rafael Luis Kessler et al. MOLECULAR MICROBIOLOGY
- Leishmania and other intracellular pathogens: selectivity, drug distribution and PK–PD
- (2017) SIMON L. CROFT PARASITOLOGY
- Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America
- (2017) Eloan Pinheiro et al. Revista da Sociedade Brasileira de Medicina Tropical
- Chagas disease research and development: Is there light at the end of the tunnel?
- (2017) Eric Chatelain Computational and Structural Biotechnology Journal
- Current drug therapy and pharmaceutical challenges for Chagas disease
- (2016) José Bermudez et al. ACTA TROPICA
- Progress Report on Neglected Tropical Disease Drug Donation Programs
- (2016) Joshua P. Cohen et al. CLINICAL THERAPEUTICS
- Advances in structure-based drug discovery of carbonic anhydrase inhibitors
- (2016) Claudiu T. Supuran Expert Opinion on Drug Discovery
- Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity
- (2016) Claudiu T Supuran Future Medicinal Chemistry
- Un modèle alternatif et innovant de Recherche et Développement pour garantir l’accès aux médicaments
- (2016) Bernard Pécoul M S-MEDECINE SCIENCES
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- Autochthonous Transmission of Trypanosoma Cruzi in Southern California
- (2016) Salvador Hernandez et al. Open Forum Infectious Diseases
- Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly SensitiveIn VivoImaging
- (2015) Amanda Fortes Francisco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The use of posaconazole against Chagas disease
- (2015) Israel Molina et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives
- (2015) Maria-Jesus Pinazo et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole
- (2015) Bianca Zingales et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy
- (2015) Carlos A. Morillo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3highregulatory T cells in humans
- (2015) Makoto Miyara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Translational challenges of animal models in Chagas disease drug development: a review
- (2015) Eric Chatelain et al. Drug Design Development and Therapy
- New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
- (2015) Imanol Peña et al. Scientific Reports
- Aptamer-Based Detection of Disease Biomarkers in Mouse Models for Chagas Drug Discovery
- (2015) Fernanda Fortes de Araujo et al. PLoS Neglected Tropical Diseases
- A Clinical Adverse Drug Reaction Prediction Model for Patients with Chagas Disease Treated with Benznidazole
- (2014) Gilberto Marcelo Sperandio da Silva et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease
- (2014) Maria T. Bahia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment
- (2014) Cynthia Santamaria et al. BMC INFECTIOUS DISEASES
- Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
- (2014) Bianca Zingales et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- A Genome-Wide Analysis of Genetic Diversity in Trypanosoma cruzi Intergenic Regions
- (2014) Leonardo G. Panunzi et al. PLoS Neglected Tropical Diseases
- High Throughput Screening for Anti–Trypanosoma cruzi Drug Discovery
- (2014) Julio Alonso-Padilla et al. PLoS Neglected Tropical Diseases
- Aptamer Based, Non-PCR, Non-Serological Detection of Chagas Disease Biomarkers in Trypanosoma cruzi Infected Mice
- (2014) Rana Nagarkatti et al. PLoS Neglected Tropical Diseases
- In VitroandIn VivoStudies of the Antiparasitic Activity of Sterol 14α-Demethylase (CYP51) Inhibitor VNI against Drug-Resistant Strains of Trypanosoma cruzi
- (2013) Maria de Nazaré Correia Soeiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease
- (2013) Peiwen Pan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review
- (2013) Ana Requena-Méndez et al. Expert Review of Anti-Infective Therapy
- New, Combined, and Reduced Dosing Treatment Protocols Cure Trypanosoma cruzi Infection in Mice
- (2013) J. M. Bustamante et al. JOURNAL OF INFECTIOUS DISEASES
- Cloning, Characterization, and Sulfonamide and Thiol Inhibition Studies of an α-Carbonic Anhydrase from Trypanosoma cruzi, the Causative Agent of Chagas Disease
- (2013) Peiwen Pan et al. JOURNAL OF MEDICINAL CHEMISTRY
- QSAR Modeling: Where Have You Been? Where Are You Going To?
- (2013) Artem Cherkasov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug rechallenge and treatment beyond progression—implications for drug resistance
- (2013) Elizabeth A. Kuczynski et al. Nature Reviews Clinical Oncology
- The ChEMBL bioactivity database: an update
- (2013) A. Patrícia Bento et al. NUCLEIC ACIDS RESEARCH
- Electrocardiographic Abnormalities in Trypanosoma cruzi Seropositive and Seronegative Former Blood Donors
- (2013) Antonio L. Ribeiro et al. PLoS Neglected Tropical Diseases
- Organ tropism during the acute and chronic phases of Trypanosoma cruzi infection in BALB/c mice
- (2012) LRC Oliveira et al. JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
- Transgenic parasites accelerate drug discovery
- (2012) Ana Rodriguez et al. TRENDS IN PARASITOLOGY
- Fexinidazole: A Potential New Drug Candidate for Chagas Disease
- (2012) Maria Terezinha Bahia et al. PLoS Neglected Tropical Diseases
- Sensitive and Specific Detection of Trypanosoma cruzi DNA in Clinical Specimens Using a Multi-Target Real-Time PCR Approach
- (2012) Yvonne Qvarnstrom et al. PLoS Neglected Tropical Diseases
- The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications
- (2011) Bianca Zingales et al. INFECTION GENETICS AND EVOLUTION
- Interfering with pH regulation in tumours as a therapeutic strategy
- (2011) Dario Neri et al. NATURE REVIEWS DRUG DISCOVERY
- International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients
- (2011) Alejandro G. Schijman et al. PLoS Neglected Tropical Diseases
- Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease
- (2010) J. C. Engel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina
- (2009) Sergio Sosa-Estani et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?
- (2009) Yara M Gomes et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Two approaches to discovering and developing new drugs for Chagas disease
- (2009) JH McKerrow et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI
- (2009) B Zingales et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- A new genotype of Trypanosoma cruzi associated with bats evidenced by phylogenetic analyses using SSU rDNA, cytochrome b and Histone H2B genes and genotyping based on ITS1 rDNA
- (2009) A. MARCILI et al. PARASITOLOGY
- Accidental infection by Trypanosoma cruzi follow-up by the polymerase chain reaction: case report
- (2009) Andréa Tieko Kinoshita-Yanaga et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity
- (2008) Claudiu T Supuran et al. EXPERT OPINION ON EMERGING DRUGS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started